GENE ONLINE|News &
Opinion
Blog

Solutions, Challenges, and Opportunities in Pandemic

by GeneOnline
Share To

With “Finding Cures in the Crisis” the theme, BIO Asia-Taiwan 2020 has scheduled two full sessions of presentations over two days focused entirely on strategies to combat the pandemic. These not-to-be-missed discussions will be led by world-leading experts in diagnostics, vaccine development, therapeutics, and public health.

In addition to these two sessions, there are many more forward-looking topics covering the “post-COVID19” challenges and trends on the regulatory, government policy, technology, and the global business and partnering model.

Learn how Taiwan successfully beat the odds, held back the COVID-19 threat, and take a close look at new treatments under development in labs and clinics not just in Asia but around the world.

The first major biomedical conference to be held in Asia since the onset of the pandemic, BIO Asia–Taiwan 2020 will take you to the front line where companies, research institutes, and governments are working tirelessly on this critical mission.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Saudi Arabia Reveals Grand Ambition to Become a Global Biotech Powerhouse by 2040
2024-01-26
Arab Health Congress Confirms Partnership with Dubai Health Authority
2024-01-12
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top